Herceptin (Trastuzumab)
Indicated for the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric cancer
Looking for more detailed information?
For regulatory reasons we are not able to provide further details on our products on this website, but more information may be available on our local website.
Please choose your country of residence to access available information in your language.